Development of a Non-invasive Assessment of Hypoxia and Neovascularization with Magnetic Resonance Imaging in Benign and Malignant Breast Tumors: Initial Results

[1]  H. Dehghani,et al.  Cerebral Oxygenation in Traumatic Brain Injury: Can a Non-Invasive Frequency Domain Near-Infrared Spectroscopy Device Detect Changes in Brain Tissue Oxygen Tension as Well as the Established Invasive Monitor? , 2019, Journal of neurotrauma.

[2]  T. Hasebe,et al.  Intracellular hypoxia measured by 18F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer , 2018, Breast Cancer Research.

[3]  K. Mouridsen,et al.  Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  L. Meng,et al.  Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. , 2014, The Cochrane database of systematic reviews.

[5]  A. Doerfler,et al.  Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy , 2017, Scientific Reports.

[6]  M. Shekhar,et al.  Breast cancer complexity: implications of intratumoral heterogeneity in clinical management , 2017, Cancer and Metastasis Reviews.

[7]  T. Yamane,et al.  Bevacizumab Induces Acute Hypoxia and Cancer Progression in Patients with Refractory Breast Cancer: Multimodal Functional Imaging and Multiplex Cytokine Analysis , 2017, Clinical Cancer Research.

[8]  Fernando Calamante,et al.  Gadolinium deposition in the brain: summary of evidence and recommendations , 2017, The Lancet Neurology.

[9]  M. Buchfelder,et al.  MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas. , 2017, Radiology.

[10]  V. Runge.  Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authori , 2017, Investigative radiology.

[11]  A. Doerfler,et al.  Magnetic resonance imaging biomarkers for clinical routine assessment of microvascular architecture in glioma , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  G. Semenza,et al.  The hypoxic tumor microenvironment: A driving force for breast cancer progression. , 2016, Biochimica et biophysica acta.

[13]  V. Runge.  Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus , 2016, Investigative radiology.

[14]  David Robert Grimes,et al.  The Role of Oxygen in Avascular Tumor Growth , 2016, bioRxiv.

[15]  A. Adamczyk,et al.  Correlation between blood and lymphatic vessel density and results of contrast-enhanced spectral mammography. , 2015, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[16]  Charles Swanton,et al.  Clinical management of breast cancer heterogeneity , 2015, Nature Reviews Clinical Oncology.

[17]  T. Helbich,et al.  Breast MRI: EUSOBI recommendations for women’s information , 2015, European Radiology.

[18]  P. Vaupel,et al.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. , 2015, Antioxidants & redox signaling.

[19]  Martin Wolf,et al.  Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial , 2015, BMJ : British Medical Journal.

[20]  Salvatore Piscuoglio,et al.  Breast cancer intra-tumor heterogeneity , 2014, Breast Cancer Research.

[21]  E Boven,et al.  Breast cancer classification by proteomic technologies: current state of knowledge. , 2014, Cancer treatment reviews.

[22]  Arvind P Pathak,et al.  Assessing breast cancer angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant? , 2013, Magnetic resonance in medicine.

[23]  W. Mali,et al.  Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast , 2013, Breast Cancer Research and Treatment.

[24]  Z. Delproposto,et al.  Differentiation of Breast Cancer from Fibroadenoma with Dual-Echo Dynamic Contrast-Enhanced MRI , 2013, PloS one.

[25]  T. Aas,et al.  Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. , 2013, Breast.

[26]  Guangyu Liu,et al.  18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer , 2013, The Journal of Nuclear Medicine.

[27]  Bruce R. Rosen,et al.  Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy , 2013, Nature Medicine.

[28]  V. Kiselev,et al.  Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic susceptibility contrast imaging , 2012, Magnetic resonance in medicine.

[29]  Albert Gjedde,et al.  Oxygen Consumption and Blood Flow Coupling in Human Motor Cortex during Intense Finger Tapping: Implication for a Role of Lactate , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  Matus Straka,et al.  Measuring brain oxygenation in humans using a multiparametric quantitative blood oxygenation level dependent MRI approach , 2012, Magnetic resonance in medicine.

[31]  Craig K. Jones,et al.  Applications of stimulated echo correction to multicomponent T2 analysis , 2012, Magnetic resonance in medicine.

[32]  P. Lønning,et al.  Vascular proliferation is a prognostic factor in breast cancer , 2012, Breast Cancer Research and Treatment.

[33]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[34]  D. Collins,et al.  Vascular characterisation of triple negative breast carcinomas using dynamic MRI , 2011, European Radiology.

[35]  D. Collins,et al.  Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy. , 2010, Radiology.

[36]  L. Carey,et al.  Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy. , 2009, Seminars in radiation oncology.

[37]  G. Song,et al.  Role of hypoxia in the hallmarks of human cancer , 2009, Journal of cellular biochemistry.

[38]  Christine Preibisch,et al.  Exponential excitation pulses for improved water content mapping in the presence of background gradients , 2008, Magnetic resonance in medicine.

[39]  Peter Vaupel,et al.  Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. , 2008, The oncologist.

[40]  C. Sotiriou,et al.  Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures , 2007, Breast Cancer Research.

[41]  C. McArdle,et al.  Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer , 2007, British Journal of Cancer.

[42]  Matilde Inglese,et al.  Microvessel density estimation in the human brain by means of dynamic contrast‐enhanced echo‐planar imaging , 2006, Magnetic resonance in medicine.

[43]  I. Buvat,et al.  Perfusion-weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement. , 2006, AJNR. American journal of neuroradiology.

[44]  Albert Gjedde,et al.  Cerebral Metabolic Response to Low Blood Flow: Possible Role of Cytochrome Oxidase Inhibition , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  Patrick Nicolas,et al.  Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.

[46]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.

[47]  Peter M. Schlag,et al.  Tumor oxygenation correlates with molecular growth determinants in breast cancer , 1998, Breast Cancer Research and Treatment.

[48]  Jonathan Charles Goddard,et al.  A computer image analysis system for microvessel density measurement in solid tumours , 2004, Angiogenesis.

[49]  N. Weidner,et al.  Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma — results of a multiparametric study , 2004, Breast Cancer Research and Treatment.

[50]  S. Tsutsui,et al.  Prognostic value of microvessel density in invasive ductal carcinoma of the breast , 2003, Breast cancer.

[51]  Albert Gjedde,et al.  Cerebral Blood Flow Change in Arterial Hypoxemia Is Consistent with Negligible Oxygen Tension in Brain Mitochondria , 2002, NeuroImage.

[52]  Daniel B Kopans,et al.  Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging--initial results. , 2002, Radiology.

[53]  T. H. van der Kwast,et al.  High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. , 2001, Cancer research.

[54]  MR-tomographische Charakteri-sierung suspekter Mammabefunde mittels suszeptibilitätsgewichteter T2*-Sequenzen , 2001 .

[55]  [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences]. , 2001, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[56]  S. Lundgren,et al.  Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. , 2000, Radiology.

[57]  P. Vaupel,et al.  Hypoxia and Radiation Response in Human Tumors. , 1996, Seminars in radiation oncology.

[58]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[59]  P. Vaupel,et al.  Tumor blood flow: The principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo , 1989, International journal of cancer.